The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose This study aimed to determine whether the diagnosis, treatment approach, and prognosis of multiple myeloma (MM) vary according to the presence and type of disability. Materials and Methods Demographic, socioeconomic, and medical data were obtained from the National Disability Database, the Korean Central Cancer Registry, and the Korean National Health Insurance claims database. An age- and sex-matched cohort was established using a 1:3 ratio constituted with 2,776,450 people with disabilities and 8,329,350 people without disabilities. Adult patients diagnosed with MM were subsequently selected from this cohort. Disabilities were categorized as physical, communication, intellectual or psychological, and affecting the major internal organs. Results The cohort included 4,090 patients with MM, with a significantly lower rate per 100,000 persons among people with disabilities than among people without disabilities (29.1 vs. 39.4, p < 0.001). People with disabilities were more likely to undergo dialysis treatment at the time of diagnosis (16.3% vs. 10.0%, p < 0.001), but were less likely to undergo autologous stem cell transplantation (37.5% vs. 43.7%, p=0.072). This trend was more evident among patients with intellectual or psychological disabilities. The median overall survival among patients with disabilities was significantly shorter than that among patients without disabilities (36.8 months vs. 51.2 months, p < 0.001). Conclusion In Korea, people with disabilities generally have a lower rate of MM diagnosis, receive less intensive treatment, and have a lower survival rate than people without disabilities.
Abstract
Purpose This study aimed to determine whether the diagnosis, treatment approach, and prognosis of multiple myeloma (MM) vary according to the presence and type of disability. Materials and Methods Demographic, socioeconomic, and medical data were obtained from the National Disability Database, the Korean Central Cancer Registry, and the Korean National Health Insurance claims database. An age- and sex-matched cohort was established using a 1:3 ratio constituted with 2,776,450 people with disabilities and 8,329,350 people without disabilities. Adult patients diagnosed with MM were subsequently selected from this cohort. Disabilities were categorized as physical, communication, intellectual or psychological, and affecting the major internal organs. Results The cohort included 4,090 patients with MM, with a significantly lower rate per 100,000 persons among people with disabilities than among people without disabilities (29.1 vs. 39.4, p < 0.001). People with disabilities were more likely to undergo dialysis treatment at the time of diagnosis (16.3% vs. 10.0%, p < 0.001), but were less likely to undergo autologous stem cell transplantation (37.5% vs. 43.7%, p=0.072). This trend was more evident among patients with intellectual or psychological disabilities. The median overall survival among patients with disabilities was significantly shorter than that among patients without disabilities (36.8 months vs. 51.2 months, p < 0.001). Conclusion In Korea, people with disabilities generally have a lower rate of MM diagnosis, receive less intensive treatment, and have a lower survival rate than people without disabilities.
참고문헌 (30)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
- Hyeon Jin Park, "Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008", Blood Research, 47(1), pp.28~38 (2012), 대한혈액학회
- Auner HW, "Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe : increased use and improved outcomes in elderly patients in recent years", Bone Marrow Transplant, 50, pp.209~215 (2015)
- Brenner H, "Recent major improvement in long-term survival of younger patients with multiple myeloma", Blood, 111, pp.2521~2526 (2008)
- Kumar SK, "Continued improvement in survival in multiple myeloma : changes in early mortality and outcomes in older patients", Leukemia, 28, pp.1122~1128 (2014)
- National survey on persons with disabilities, "Korean Statistical Information Service", Korea Institute for Health and Social Affairs, ~ (2011)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009", Cancer Research and Treatment, 44(1), pp.11~24 (2012), 대한암학회
- Jee SH, "Bodymass index and mortality in Korean men and women", N Engl J Med, 355, pp.779~787 (2006)
- Kim YI, "Longterm metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment : a nationwide cohort study", Aliment Pharmacol Ther, 39, pp.854~863 (2014)
- Seong SC, "Data resource profile : The National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- "Number of registered disabled people" (2017)[URL]
- Yoon TH, "Inequalities in medical care utilization by South Korean cancer patients according to income : a retrospective cohort study", Int J Health Serv, 41, pp.51~66 (2011)
- Fonseca R, "Trends in overall survival and costs of multiple myeloma, 2000-2014", Leukemia, 31, pp.1915~1921 (2017)
- Cowan AJ, "Global burden of multiple myeloma : a systematic analysis for the Global Burden of Disease Study 2016", JAMA Oncol, 4, pp.1221~1227 (2018)
- Fujiura GT, "Analysis of ethnic variations in developmental disability prevalence and household economic status", Ment Retard, 35, pp.286~294 (1997)
- Smith JP, "Healthy bodies and thick wallets : the dual relation between health and economic status", J Econ Perspect, 13, pp.144~166 (1999)
- Emerson E, "Mothers of children and adolescents with intellectual disability : social and economic situation, mental health status, and the self-assessed social and psychological impact of the child's difficulties", J Intellect Disabil Res, 47(Pt 4-5), pp.385~399 (2003)
- Stabile M, "The economic costs of childhood disability", Future Child, 22, pp.65~96 (2012)
- Kavanagh AM, "Intersections between disability, type of impairment, gender and socio-economic disadvantage in a nationally representative sample of 33, 101 working-aged Australians", Disabil Health J, 8, pp.191~199 (2015)
- Halpern MT, "Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites : a retrospective analysis", Lancet Oncol, 9, pp.222~231 (2008)
- Byers TE, "The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study", Cancer, 113, pp.582~591 (2008)
- Frederiksen BL, "Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark : a nationwide study", Br J Cancer, 106, pp.988~995 (2012)
- Coppus AM, "People with intellectual disability: what do we know about adulthood and life expectancy?", Dev Disabil Res Rev, 18, pp.6~16 (2013)
- Patja K, "Life expectancy of people with intellectual disability : a 35-year follow-up study", J Intellect Disabil Res, 44(Pt 5), pp.591~599 (2000)
- Haveman M, "Ageing and health status in adults with intellectual disabilities : results of the European POMONA II study", J Intellect Dev Disabil, 36, pp.49~60 (2011)
- Riddle I, "Effective communication for health care providers: a guide to caring for people with disabilities", Center for Disabilities Studies, University of Delaware, ~ (2011)
- Rajkumar SV, "Multiple myeloma : 2016 update on diagnosis, risk-stratification, and management", Am J Hematol, 91, pp.719~734 (2016)
- Kumar SK, "NCCN guidelines insights: multiple myeloma, version 3.2018", J Natl Compr Canc Netw, 16, pp.11~20 (2018)
- Cavo M, "The multiple myeloma treatment landscape : international guideline recommendations and clinical practice in Europe", Expert Rev Hematol, 11, pp.219~237 (2018)
- Kristinsson SY, "Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden", J Clin Oncol, 27, pp.2073~2080 (2009)